Cipla issues clarification with regards to stake sale by the Promoters
Ms. Samina Hamied, Executive Vice Chairperson, Cipla issued below statement with regards to sale of 2,01,69,756 ...
Read more
Tag: cipla
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild ...
Read more
Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test
Cipla Limited today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for ...
Read more
Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India
Cipla Limited today announced it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly ...
Read more
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail for treatment of Covid-19
Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients ...
Read more
Cipla & Alkem also joins ABCD Technologies LLP
Alkem Laboratories Limited & Cipla Limited has entered into an agreement to become a partner in ...
Read more
Cipla reappoints Umang Vohra as Managing Director
Cipla announced Re-appointment of Mr. Umang Vohra as Managing Director and Global Chief Executive Officer of the ...
Read more
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership
Cipla Therapeutics, a divison of Cipla USA, Inc., an affiliate of Cipla Limited and SIGA Technologies, ...
Read more